News for hackers. Stuff that matters.

A comment on AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor. Parent comment

Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by fnands on Tuesday January 25, 2022 @05:14AM (#30070208)
Eh, I would argue there is a massive difference between drug discovery and patient care, which was what Watson was aiming for.

Filtering out useful molecules from useless (or dangerous) ones is a nicely contained (if difficult) problem that ML is pretty good at solving.

[ Parent | on HN ]
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by ramraj07 on Tuesday January 25, 2022 @05:37AM (#30070328)
To say Watson was aiming for anything is an injustice to the word Aim.
[ Parent | on HN ]
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by Closi on Tuesday January 25, 2022 @06:20AM (#30070594)
How about "Watson was aiming to sell consulting services"?
[ Parent | on HN ]
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by TaylorAlexander on Tuesday January 25, 2022 @06:10AM (#30070529)
Aiming to market IBM as cool.
[ Parent | on HN ]
Re:AlphaFold-Powered Drug Discovery of a Novel CDK20 Inhibitor by bayesian_horse on Tuesday January 25, 2022 @06:08AM (#30070519)
AlphaFold doesn't sort out molecules. This paper took the 3D model of a protein predicted by the original AlphaFold paper and used that to test random small molecules against it, first virtually then physically.
[ Parent | on HN ]